The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab
Linear psoriasis is an unusual clinical variation of psoriasis that manifests segmentally along the lines of Blaschko. A major differential diagnosis is inflammatory linear verrucous epidermal nevus (ILVEN). The treatment of linear psoriasis is often challenging, with inadequate response to biologic...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Case Reports in Dermatological Medicine |
Online Access: | http://dx.doi.org/10.1155/2017/3280215 |
id |
doaj-f0c4200d4d36413e9adb11cfea26560d |
---|---|
record_format |
Article |
spelling |
doaj-f0c4200d4d36413e9adb11cfea26560d2020-11-25T01:11:45ZengHindawi LimitedCase Reports in Dermatological Medicine2090-64632090-64712017-01-01201710.1155/2017/32802153280215The Successful Treatment of a Case of Linear Psoriasis with IxekizumabSara Ghoneim0Alvaro J. Ramos-Rodriguez1Fernando Vazquez de Lara2Lauren Bonomo3Saba University School of Medicine, The Bottom, NetherlandsIcahn School of Medicine at Mount Sinai West, New York, NY, USAIcahn School of Medicine at Mount Sinai West, New York, NY, USAIcahn School of Medicine at Mount Sinai, New York, NY, USALinear psoriasis is an unusual clinical variation of psoriasis that manifests segmentally along the lines of Blaschko. A major differential diagnosis is inflammatory linear verrucous epidermal nevus (ILVEN). The treatment of linear psoriasis is often challenging, with inadequate response to biological agents reported in the literature. We report a case of a 25-year-old African-American female who presented with asymptomatic hyperkeratotic papules along the lines of Blaschko and was subsequently diagnosed with linear psoriasis. After failing conventional treatment regimens, the patient received a trial of ixekizumab with complete resolution of cutaneous lesions reported after 4 months and only 8 doses of the anti-IL-17 biologic agent.http://dx.doi.org/10.1155/2017/3280215 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sara Ghoneim Alvaro J. Ramos-Rodriguez Fernando Vazquez de Lara Lauren Bonomo |
spellingShingle |
Sara Ghoneim Alvaro J. Ramos-Rodriguez Fernando Vazquez de Lara Lauren Bonomo The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab Case Reports in Dermatological Medicine |
author_facet |
Sara Ghoneim Alvaro J. Ramos-Rodriguez Fernando Vazquez de Lara Lauren Bonomo |
author_sort |
Sara Ghoneim |
title |
The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_short |
The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_full |
The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_fullStr |
The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_full_unstemmed |
The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab |
title_sort |
successful treatment of a case of linear psoriasis with ixekizumab |
publisher |
Hindawi Limited |
series |
Case Reports in Dermatological Medicine |
issn |
2090-6463 2090-6471 |
publishDate |
2017-01-01 |
description |
Linear psoriasis is an unusual clinical variation of psoriasis that manifests segmentally along the lines of Blaschko. A major differential diagnosis is inflammatory linear verrucous epidermal nevus (ILVEN). The treatment of linear psoriasis is often challenging, with inadequate response to biological agents reported in the literature. We report a case of a 25-year-old African-American female who presented with asymptomatic hyperkeratotic papules along the lines of Blaschko and was subsequently diagnosed with linear psoriasis. After failing conventional treatment regimens, the patient received a trial of ixekizumab with complete resolution of cutaneous lesions reported after 4 months and only 8 doses of the anti-IL-17 biologic agent. |
url |
http://dx.doi.org/10.1155/2017/3280215 |
work_keys_str_mv |
AT saraghoneim thesuccessfultreatmentofacaseoflinearpsoriasiswithixekizumab AT alvarojramosrodriguez thesuccessfultreatmentofacaseoflinearpsoriasiswithixekizumab AT fernandovazquezdelara thesuccessfultreatmentofacaseoflinearpsoriasiswithixekizumab AT laurenbonomo thesuccessfultreatmentofacaseoflinearpsoriasiswithixekizumab AT saraghoneim successfultreatmentofacaseoflinearpsoriasiswithixekizumab AT alvarojramosrodriguez successfultreatmentofacaseoflinearpsoriasiswithixekizumab AT fernandovazquezdelara successfultreatmentofacaseoflinearpsoriasiswithixekizumab AT laurenbonomo successfultreatmentofacaseoflinearpsoriasiswithixekizumab |
_version_ |
1725169869249314816 |